Pappalysin 2 (PAPPA2) mutation, occurring most frequently in skin cutaneous melanoma (SKCM) and non‐small cell lung cancer (NSCLC), is found to be related to anti‐tumour immune response. However, the association… Click to show full abstract
Pappalysin 2 (PAPPA2) mutation, occurring most frequently in skin cutaneous melanoma (SKCM) and non‐small cell lung cancer (NSCLC), is found to be related to anti‐tumour immune response. However, the association between PAPPA2 and the efficacy of immune checkpoint inhibitors (ICIs) therapy remains unknown.
Keywords:
cell;
non small;
pappa2 mutation;
pappa2;
skin cutaneous;
cutaneous melanoma
Journal Title: Cell Proliferation
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cell Proliferation
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!